Roberto Padoan

1.3k total citations
53 papers, 397 citations indexed

About

Roberto Padoan is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Physiology. According to data from OpenAlex, Roberto Padoan has authored 53 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pulmonary and Respiratory Medicine, 23 papers in Rheumatology and 14 papers in Physiology. Recurrent topics in Roberto Padoan's work include Vasculitis and related conditions (28 papers), Otitis Media and Relapsing Polychondritis (11 papers) and Asthma and respiratory diseases (7 papers). Roberto Padoan is often cited by papers focused on Vasculitis and related conditions (28 papers), Otitis Media and Relapsing Polychondritis (11 papers) and Asthma and respiratory diseases (7 papers). Roberto Padoan collaborates with scholars based in Italy, United Kingdom and United States. Roberto Padoan's co-authors include Franco Schiavon, Mara Felicetti, Diego Cazzador, Andrea Doria, Elisabetta Zanoletti, Ennio Nardello, Mariele Gatto, Alvise Berti, Giuseppe Paolazzi and Roberto Bovo and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Immunology and Annals of the Rheumatic Diseases.

In The Last Decade

Roberto Padoan

47 papers receiving 385 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roberto Padoan Italy 11 254 153 99 65 59 53 397
Bernhard Noelle Germany 6 311 1.2× 145 0.9× 145 1.5× 60 0.9× 36 0.6× 6 422
Caterina Marinelli Italy 7 171 0.7× 99 0.6× 76 0.8× 8 0.1× 88 1.5× 12 486
Mehmet Umut Akyol Türkiye 13 142 0.6× 44 0.3× 70 0.7× 24 0.4× 202 3.4× 26 433
H.-F. Petereit Germany 14 41 0.2× 121 0.8× 38 0.4× 20 0.3× 38 0.6× 29 594
Miranda C. Marion United States 11 51 0.2× 121 0.8× 35 0.4× 12 0.2× 23 0.4× 15 405
Subimal Roy India 13 81 0.3× 23 0.2× 21 0.2× 163 2.5× 78 1.3× 29 473
Mitsuomi Kaimori Japan 16 172 0.7× 49 0.3× 53 0.5× 31 0.5× 270 4.6× 51 751
Hüseyin Katılmış Türkiye 12 151 0.6× 22 0.1× 98 1.0× 6 0.1× 153 2.6× 41 418
Sedat Öztürkcan Türkiye 13 109 0.4× 31 0.2× 50 0.5× 13 0.2× 161 2.7× 41 414
Martin L. Fishman United States 10 184 0.7× 88 0.6× 87 0.9× 31 0.5× 41 0.7× 12 613

Countries citing papers authored by Roberto Padoan

Since Specialization
Citations

This map shows the geographic impact of Roberto Padoan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Padoan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Padoan more than expected).

Fields of papers citing papers by Roberto Padoan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberto Padoan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Padoan. The network helps show where Roberto Padoan may publish in the future.

Co-authorship network of co-authors of Roberto Padoan

This figure shows the co-authorship network connecting the top 25 collaborators of Roberto Padoan. A scholar is included among the top collaborators of Roberto Padoan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberto Padoan. Roberto Padoan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bond, Milena, et al.. (2025). Advances in the treatment of polymyalgia rheumatica. Lara D. Veeken. 64(Supplement_1). i48–i54. 1 indexed citations
2.
3.
Baggio, Chiara, Francesca Oliviero, Roberto Padoan, et al.. (2024). Expanding the VEXAS diagnostic workup: the role of peripheral blood cytological analysis. Frontiers in Immunology. 15. 1466720–1466720. 2 indexed citations
4.
Padoan, Roberto, et al.. (2024). Dupilumab for refractory chronic rhinosinusitis in eosinophilic granulomatosis with polyangiitis. Lara D. Veeken. 64(5). 2892–2901. 2 indexed citations
5.
Cazzador, Diego, et al.. (2024). Cocaine- and Levamisole-Induced Vasculitis: Defining the Spectrum of Autoimmune Manifestations. Journal of Clinical Medicine. 13(17). 5116–5116. 1 indexed citations
6.
Bindoli, Sara, Roberto Padoan, Eugenia Bertoldo, et al.. (2024). The role of 18FDG–PET imaging in VEXAS syndrome: a multicentric case series and a systematic review of the literature. Internal and Emergency Medicine. 19(8). 2331–2345. 2 indexed citations
7.
Pizzi, Marco, Diego Cecchin, Anna Ghirardello, et al.. (2024). Cutting-Edge Strategies for Renal Tumour-like Lesions in Granulomatosis with Polyangiitis: A Systematic Review. Diagnostics. 14(5). 566–566. 1 indexed citations
8.
9.
Ghirardello, Anna, Mariele Gatto, Elisabetta Zanatta, et al.. (2023). Detection of Myositis Autoantibodies by Multi-Analytic Immunoassays in a Large Multicenter Cohort of Patients with Definite Idiopathic Inflammatory Myopathies. Diagnostics. 13(19). 3080–3080. 10 indexed citations
10.
Tomelleri, Alessandro, Roberto Padoan, Chengappa Kavadichanda, et al.. (2023). Validation of the 2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis. Lara D. Veeken. 62(10). 3427–3432. 12 indexed citations
11.
Marchi, Maria Rita, et al.. (2023). Combination of monoclonal antibodies targeting type 2 inflammation for severe asthma and eosinophilic granulomatosis with polyangiitis. Autoimmunity Reviews. 23(3). 103503–103503. 5 indexed citations
12.
Salvarani, Carlo, Roberto Padoan, Alessandro Tomelleri, et al.. (2023). Subclinical giant cell arteritis in polymyalgia rheumatica: Concurrent conditions or a common spectrum of inflammatory diseases?. Autoimmunity Reviews. 23(1). 103415–103415. 23 indexed citations
13.
Ughi, Nicola, Roberto Padoan, Chiara Crotti, et al.. (2022). The Italian Society of Rheumatology clinical practice guidelines for the management of large vessel vasculitis. SHILAP Revista de lepidopterología. 73(4). 7 indexed citations
14.
Pizzi, Marco, et al.. (2022). Whipple’s aortitis. Lara D. Veeken. 61(9). e294–e294. 1 indexed citations
15.
Padoan, Roberto, et al.. (2022). Biologic therapy in relapsing polychondritis: navigating between options. Expert Opinion on Biological Therapy. 22(5). 661–671. 2 indexed citations
16.
Padoan, Roberto, Mariele Gatto, Anna Ghirardello, et al.. (2021). IgG anti-Pentraxin 3 antibodies are a novel biomarker of ANCA-associated vasculitis and better identify patients with eosinophilic granulomatosis with polyangiitis. Journal of Autoimmunity. 124. 102725–102725. 15 indexed citations
17.
Padoan, Roberto, Fulvia Chieco Bianchi, Maria Rita Marchi, et al.. (2020). Benralizumab as a glucocorticoid-sparing treatment option for severe asthma in eosinophilic granulomatosis with polyangiitis. The Journal of Allergy and Clinical Immunology In Practice. 8(9). 3225–3227.e2. 26 indexed citations
18.
Padoan, Roberto, Diego Cazzador, Alfonso Luca Pendolino, et al.. (2019). Cogan’s syndrome: new therapeutic approaches in the biological era. Expert Opinion on Biological Therapy. 19(8). 781–788. 14 indexed citations
19.
Felicetti, Mara, Diego Cazzador, Roberto Padoan, et al.. (2018). Ear, nose and throat involvement in granulomatosis with polyangiitis: how it presents and how it determines disease severity and long-term outcomes. Clinical Rheumatology. 37(4). 1075–1083. 48 indexed citations
20.
Padoan, Roberto, et al.. (2007). G.P.4.07 Relation between LGMD2B progression and physical activity. Neuromuscular Disorders. 17(9-10). 789–789. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bernhard Noelle Breakdown of academic impact, for papers by Caterina Marinelli Breakdown of academic impact, for papers by Mehmet Umut Akyol Breakdown of academic impact, for papers by H.-F. Petereit Breakdown of academic impact, for papers by Miranda C. Marion Breakdown of academic impact, for papers by Subimal Roy Breakdown of academic impact, for papers by Mitsuomi Kaimori Breakdown of academic impact, for papers by Hüseyin Katılmış Breakdown of academic impact, for papers by Sedat Öztürkcan Breakdown of academic impact, for papers by Martin L. Fishman
Rankless by CCL
2026